↓ Skip to main content

Arbaclofen in fragile X syndrome: results of phase 3 trials

Overview of attention for article published in Journal of Neurodevelopmental Disorders, June 2017
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#19 of 507)
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news
10 news outlets
twitter
8 X users

Citations

dimensions_citation
139 Dimensions

Readers on

mendeley
200 Mendeley